Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Daxor Corp DXR

Healthcare Medical Devices

Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific... see more

Add To Watchlist

Recent & Breaking News (NDAQ:DXR)

Daxor Receives Two Patents, One for Measurement of Total Body Albumin and a Second Patent for Improved Accuracy of Blood Volume Measurement

Marketwired April 9, 2015

Daxor Receives Notification of Patent Approval and Issues an Update on its Stock Buyback Program

Marketwired March 17, 2015

Daxor Corporation Announces Placement of Two BVA-100 Blood Volume Analyzers

Marketwired March 13, 2015

Daxor Corporation Announces Filing of Form N-CSR for December 31, 2014

Marketwired February 27, 2015

Daxor Corporation Announces Major Research Studies

Marketwired January 30, 2015

Daxor Corporation Appoints Michael Feldschuh as Executive Vice President

Marketwired December 18, 2014

Daxor Corporation Announces a Major Study With the Mayo Clinic

Marketwired December 11, 2014

Daxor Corporation Announces Payment of a Dividend

Marketwired November 17, 2014

Daxor Announces Publication of a Study Comparing Two Widely Used Surrogate Tests for Estimating Blood Volume With Direct Measurement of Blood Volume

Marketwired November 3, 2014

Daxor Corporation Announces Research Agreement With Virginia Commonwealth University on Burn Patients

Marketwired October 21, 2014

Daxor Corporation Announces Filing of Form N-CSR for June 30, 2014

Marketwired August 29, 2014

Daxor to Explore Possible Partnership or Partial Sale of the Company

Marketwired June 19, 2014

Heart Failure Study From the Mayo Clinic Utilizing Daxor's BVA-100 Blood Volume Analyzer Published in Journal of the American College of Cardiology - Heart Failure

Marketwired May 30, 2014

Daxor Corporation's Idant Laboratories Subsidiary Earns American Association of Blood Banks (AABB) Accreditation Again

Marketwired April 30, 2014

Daxor Corporation's Idant Laboratories Subsidiary Earns American Association of Blood Banks (AABB) Accreditation Again

Marketwired April 30, 2014

Dr. Feldschuh, CEO of Daxor, Returned to Work After Fracturing a Hip, Speaks About Extensive Blood Loss; Daxor Will Provide a New Service to Hospitals and Patients

Marketwired April 10, 2014

Dr. Feldschuh, CEO of Daxor, Returned to Work After Fracturing a Hip, Speaks About Extensive Blood Loss; Daxor Will Provide a New Service to Hospitals and Patients

Marketwired April 10, 2014

Daxor Corporation Announces Filing of Form N-CSR for December 31, 2013

Marketwired February 28, 2014

Daxor Corporation Announces Dr. Joseph Feldschuh, President and CEO, Sustained a Fractured Hip, Had Emergency Surgery, and Received a Transfusion of His Own Frozen Blood Which Had Been Stored Four Years Ago

Marketwired February 11, 2014

Daxor Announces a Research Study That Proves Micro Samples Are Feasible for Accurate Blood Volume Measurements on Infants and Small Children Utilizing the BVA-100 Blood Volume Analyzer

Marketwired January 15, 2014